CALC - CalciMedica, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 5.6

Open

$ 5.60

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 5.60 - $ 5.60

52 Week Range

$ 1.75 - $ 8.59

Volume

3,585

Average Volume

Market Cap

25.12M

Beta (5Y Monthly)

$ 1.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	03-09-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-11-2022	12-31-2021	10-K
10	11-12-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	05-14-2021	03-31-2021	10-Q
13	03-05-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

CalciMedica Announces Last Patient Enrolle...
04/24/2024 12:08:00

Full target enrollment of 216 patients achieved Topline data from CARPO expected in 2Q 2024 LA JOLLA, Calif., April 24, 2024 /P...

calcimedica-and-2-other-penny-stocks-insiders-are-buying

CalciMedica And 2 Other Penny Stocks Insid...
04/03/2024 13:13:02

The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their con...

Oppenheimer Maintains Outperform on CalciM...
04/01/2024 13:16:21

Oppenheimer analyst Leland Gershell maintains CalciMedica (NASDAQ:CALC) with a Outperform and maintains $14 price target.

HC Wainwright & Co. Reiterates Buy on Calc...
04/01/2024 10:30:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

CalciMedica Q4 EPS $(0.23)
03/28/2024 12:45:37

CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.23) per share.

CalciMedica FY23 EPS $(7.66) Vs $(111.16) YoY
03/28/2024 11:28:52

HC Wainwright & Co. Reiterates Buy on Calc...
03/13/2024 16:39:32

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

CalciMedica Presents Data From Preclinical...
03/13/2024 12:12:09

Therapeutic treatment with Auxora shown to hasten the recovery of kidney function and improve survival in a rat model of acute ...

Reported Earlier, CalciMedica To Present D...
02/29/2024 09:08:47

Preclinical data show that therapeutic treatment with Auxora in a rat model of AKI improves kidney function as measured by glom...

JonesTrading Initiates Coverage On CalciMe...
02/16/2024 11:46:31

JonesTrading analyst Catherine Novack initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and announces Price ...

HC Wainwright & Co. Reiterates Buy on Calc...
02/13/2024 17:37:09

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $20 price tar...

top-4-health-care-stocks-that-may-crash-this-quarter

Top 4 Health Care Stocks That May Crash Th...
02/02/2024 13:21:44

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a...

5-value-stocks-to-watch-in-the-healthcare-sector

5 Value Stocks To Watch In The Healthcare ...
01/29/2024 14:44:11

HC Wainwright & Co. Initiates Coverage On ...
01/29/2024 11:28:08

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and annou...

CalciMedica Announces Private Placement Of...
01/22/2024 13:02:52

$20.4 million in upfront financing with the potential to receive up to an additional approximately $34.2 million for an aggrega...

Calcimedica's Collaborator, St. Jude Child...
12/11/2023 12:38:36

Treatment with Auxora™ shown to potentially reduce the severity of asparaginase-associated pancreatitis, also called asparagi...

Oppenheimer Reiterates Outperform on Calci...
11/13/2023 17:28:23

Oppenheimer analyst Leland Gershell reiterates CalciMedica (NASDAQ:CALC) with a Outperform and maintains $14 price target.

Gannett And 3 Other Stocks Under $4 Inside...
11/07/2023 13:42:28

The Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence...

5 Value Stocks In The Healthcare Sector
10/09/2023 14:44:30

A Look Into Healthcare Sector Value Stocks
10/02/2023 14:43:55